Mustang Ebitda from 2010 to 2024
| MBIO Stock | USD 0.26 0.01 3.70% |
EBITDA | First Reported 2015-09-30 | Previous Quarter -10.3 M | Current Value -8.5 M | Quarterly Volatility 5.9 M |
Check Mustang Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mustang main balance sheet or income statement drivers, such as Interest Expense of 1.4 M, Selling General Administrative of 9 M or Total Revenue of 0.0, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 99.16. Mustang financial statements analysis is a perfect complement when working with Mustang Bio Valuation or Volatility modules.
Mustang | Ebitda |
Latest Mustang Bio's Ebitda Growth Pattern
Below is the plot of the Ebitda of Mustang Bio over the last few years. It is Mustang Bio's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mustang Bio's overall financial position and show how it may be relating to other accounts over time.
| Ebitda | 10 Years Trend |
|
Ebitda |
| Timeline |
Mustang Ebitda Regression Statistics
| Arithmetic Mean | (32,002,070) | |
| Coefficient Of Variation | (71.29) | |
| Mean Deviation | 19,638,351 | |
| Median | (30,024,000) | |
| Standard Deviation | 22,813,425 | |
| Sample Variance | 520.5T | |
| Range | 62.8M | |
| R-Value | (0.88) | |
| Mean Square Error | 130.6T | |
| R-Squared | 0.77 | |
| Significance | 0.000019 | |
| Slope | (4,467,316) | |
| Total Sum of Squares | 7286.3T |
Mustang Ebitda History
About Mustang Bio Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Mustang Bio income statement, its balance sheet, and the statement of cash flows. Mustang Bio investors use historical funamental indicators, such as Mustang Bio's Ebitda, to determine how well the company is positioned to perform in the future. Although Mustang Bio investors may use each financial statement separately, they are all related. The changes in Mustang Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Mustang Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Mustang Bio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Mustang Bio. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| EBITDA | -48.5 M | -50.9 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Mustang Bio Correlation against competitors. To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Mustang Stock analysis
When running Mustang Bio's price analysis, check to measure Mustang Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mustang Bio is operating at the current time. Most of Mustang Bio's value examination focuses on studying past and present price action to predict the probability of Mustang Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mustang Bio's price. Additionally, you may evaluate how the addition of Mustang Bio to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is Mustang Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.00) | Revenue Per Share (0) | Return On Assets (0.58) | Return On Equity (2.22) |
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.